Background: Cupressaceae (cypress) pollens can cause pollinosis in winter. However, the lack of specific commercial extracts combined with the early pollination period of cypress trees make a precise diagnosis difficult. The need for a reliable and effective cypress extract for diagnostic and therapeutic purposes is increasingly felt. Methods: Mixed or single Cupressus arizonica, lusitanica and sempervirens pollen extracts precipitated with ammonium sulfate (PPT) were compared by direct RAST, RAST inhibition and SDS-PAGE techniques. The major allergen of C. arizonica (Cup a 1), purified by anion exchange chromatography, was checked by immunoblotting experiments before chemical modification, in parallel with a C. arizonica extract, with potassium cyanate (KCNO) to obtain a monomeric allergoid. The allergoid extract was characterized for its biological, chemico-physical and immunological features by RAST inhibition, SDS-PAGE and ELISA assays. Results: Direct RAST, RAST inhibition, and SDS-PAGE data indicated that the PPT C. arizonica pollen extract showed the most allergenic potential, and it can be considered representative of the Cupressus spp. Immunoblotting data confirmed Cup a 1 as a major allergen. RAST inhibition and ELISA showed that modified PPT C. arizonica extract had less IgE reactivity than the native, non-modified extract, while preserving the immunogenic capacity typical for an allergoid. Finally, the SDS-PAGE profile of Cup a 1 allergoid was similar to native Cup a 1 allergen, suggesting the modified C. arizonica extract shows the characteristics of a monomeric allergoid. Conclusions: The PPT C. arizonica pollen extract shows good in vitro diagnostic potential and its chemically modified form offers the features of a monomeric allergoid. It might therefore lend itself to the development of a product to be administered by the sublingual or oromucosal route for immunotherapy of individuals with cypress pollinosis.

Keywords:
Cypress allergy, Cupressus arizonica pollen, Cup a 1 allergen, Potassium cyanate, Allergoid
1.
L’allergie au cyprès: Symposium International & Méditerranéen sur l’Allergie. Allergie Immunol 2000;32:83–150.
2.
Panzani R, Centanni G, Brunel M: Increase of respiratory allergy to the pollens of cypresses in the south of France. Ann Allergy 1986;56:460–463.
3.
Caiaffa MF, Macchia L, Strada S, Bariletto G, Scarpelli F, Tursi A: Airborne Cupressaceae pollen in southern Italy. Ann Allergy 1993;71:45–50.
4.
Guerra F, Daza JC, Miguel R, Moreno C, Galan C, Dominguez E, Sanchez Guijo P: Sensitivity to Cupressus: Allergenic significance in Cordoba (Spain). J Investig Allergol Clin Immunol 1996;6:117–120.
5.
Panzani R, Zerboni R, Ariano R: Allergenic significance of Cupressaceae pollen in some parts of the Mediterranean area; in D’Amato G, Spieksma FTM, Bonini S (eds): Allergenic Pollen and Pollinosis in Europe. Oxford, Blackwell, 1991, pp 81–84.
6.
Yasueda H, Yui Y, Shimuzu T, Shida T: Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen. J Allergy Clin Immunol 1983;1:77–86.
7.
Midoro-Horiuti T, Nouno S, Seino Y: Skin tests of pollen grains of Taxodiaceae and Cupressaceae in children with bronchial asthma. Acta Paediatr Jpn 1992;34:501–504.
8.
Ito H, Nishimura J, Suzuki M, Mamiya S, Sato K, Takagi I, Baba S: Specific IgE to Japanese cypress (Chamaecyparis obtusa) in patients with nasal allergy. Ann Allergy Asthma Immunol 1995;74:299–303.
9.
Subiza J, Jerez M, Jimenez JA, Narganes MJ, Cabrera M, Varela S, Subiza E: Allergenic pollen pollinosis in Madrid. J Allergy Clin Immunol 1995;96:15–23.
10.
Sposato B, Mannino F, Terzano C: Significant increase of incidence of cypress pollen allergy in the city of Rome. Recenti Prog Med 2001;92:541.
11.
Mari A, Di Felice G, Afferni C, Barletta B, Tinghino R, Pini C: Cypress allergy: An underestimated pollinosis. Allergy 1997;52:355–356.
12.
Ford SA, Baldo BA, Panzani R, Bass D: Cypress (Cupressus sempervirens) pollen allergens: Identification by proteins blotting and improved detection of specific IgE antibodies. Int Arch Allergy Appl Immunol 1991;95:178–183.
13.
Pham NH, Baldo BA, Bass DJ: Cypress pollen allergy. Identification of allergens and crossreactivity between divergent species. Clin Exper Allergy 1994;24:558–565.
14.
Di Felice G, Caiaffa MF, Bariletto G, Afferni C, Di Paola R, Mari A, Palumbo S, Tinghino R, Sallusto F, Macchia L, Pini C: Allergens of Arizona cypress (Cupressus arizonica) pollen: Characterization of the pollen extract and identification of the allergen components. J Allergy Clin Immunol 1994:94:547–555.
15.
Bar Dayan Y, Keynan N, Waisel Y, Pick AI, Tamir R: Podocarpus gracilior and Callitris verrucosa – newly identified allergens that crossreact with Cupressus sempervirens. Clin Exp Allergy 1995:25:456–460.
16.
Leduc V, Charpin D, Aparcio C, Veber C, Guérin L: Allergie au pollen de cyprès: Préparation d’un extrait de référence et standardisation in vivo. Allergie Immunol 2000;32:101–103.
17.
André C, Dumur J-P, Hrabina M, Lefebvre E, Sicard H: Juniperus ashei: le golden standard des cupressacées. Allergie Immunol 2000;32:104–106.
18.
Mari A, Di Felice G, Afferni C, Barletta B, Tinghino R, Sallusto F, Pini C: Assessment of skin prick test and serum specific IgE detection in the diagnosis of Cupressaceae pollinosis. J Allergy Clin Immunol 1996;98:21–31.
19.
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
20.
Ceska M, Eriksson R, Varga JM: Radio-immunosorbent assay of allergens. J Allergy Clin Immunol 1972;49:1–9.
21.
Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350–4354.
22.
Alisi C, Afferni C, Iacovacci P, Barletta B, Tinghino R, Butteroni C, Puggioni EMR, Wilson IBH, Federico R, Schinina ME, Ariano R, Di Felice G, Pini C: Rapid isolation, characterization and glycan analysis of Cup a 1, the major allergen of Arizona cypress (Cupressus arizonica) pollen. Allergy 2001;56:978–984.
23.
Mistrello G, Brenna O, Roncarolo D, Zanoni D, Gentili M, Falagiani P: Monomeric Chemically modified allergens: Immunologic and physicochemical characterization. Allergy 1996;51:8–15.
24.
Panzani R, Yasueda H, Shimizu T, Shida T: Cross-reactivity between the pollen of Cupressus sempervirens (common cypress) and of Cryptomeria japonica (Japanese cedar). Ann Allergy 1986;57:26–30.
25.
Afferni C, Iacovacci P, Barletta B, et al: Role of carbohydrate moieties in IgE binding to allergenic components of Cupressus arizonica pollen extract. Clin Exp Allergy 1999;29:1087–1094.
26.
Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F: Colorimetric method for determination of sugars and related substances. Anal Chem 1956;28:350.
27.
Van Ree R, Van Leeuwen A, Aalberse RC: How far can we simplify in vitro diagnostics for grass pollen allergy?: A study with 17 whole pollen extracts and purified natural and recombinant major allergens. J Allergy Clin Immunol 1998;102:184–190.
28.
Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC: Fatalities from immunotherapy (IT) and skin testing. J Allergy Clin Immunol 1987;79:660–677.
29.
Passalacqua G, Albano M, Fregonese L, Riccio A, Pronzato C, Mela GS, Canonica GW: Randomized controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998;351:629–632.
30.
Caffarelli C, Sensi LG, Marcucci F, Cavagni G: Preseasonal local allergoid immunotherapy to grass pollen in children: A double-blind, placebo-controlled, randomized trial. Allergy 2000;55:1142–1147.
31.
Lombardi C, Gargioni S, Venturi S, Zoccali P, Canonica GW, Passalacqua G: Controlled study of preseasonal immunotherapy with grass pollen extract in tablets: Effect on bronchial hyperreactivity. J Invest Allergol Clin Immunol 2001;11:41–45.
32.
Ariano R, Panzani RC, Augeri G: Efficacy and safety of oral immunotherapy in respiratory allergy to Parietaria judaica pollen. A double-blind study. Invest Allergol Clin Immunol 1998;8:155–160.
33.
Bagnasco M, Passalacqua G, Villa G, et al: Pharmacokinetics of an allergen and a monomeric allergoid for oromucosal immunotherapy in allergic volunteers. Clin Exp Allergy 2001;31:54–60.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.